Marc Hedrick | President and Chief Executive Officer |
Andrew Sims | Chief Financial Officer |
Jason McCarthy | Maxim Group |
Ed Woo | Ascendiant Capital |
Sean Lee | H.C. Wainwright |
Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Third Quarter 2020 Earnings Results Call. At this time, all participants have been placed in a listen-only mode and the floor will open for your questions following the presentation. [Operator Instructions] And before we begin, we want to advise you that, over the course of this call and question-and-answer session, forward-looking statements will be made regarding events, trends, business prospects and financial performance, which may affect Plus Therapeutics' future operating results and financial position. All such statements are subject to risk and uncertainties, including the risk and uncertainties described under the Risk Factors section included in Plus Therapeutics' annual report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission from time to time.